Skip to main content
. 2021 Mar 31;13(4):594. doi: 10.3390/v13040594

Figure 2.

Figure 2

Prevalence of INSTI DRM in the 11 HIV-1C Integrase sequences from treatment-experienced individuals with virological failure whilst on dolutegravir/INSTI based therapy. INSTI, integrase strand transfer inhibitor, DRMs drug resistance mutations.